Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
The current price of Eli Lilly And Co in the market is ï¿¥198,381.11, with a 24-hour trading volume of ï¿¥937.54M. The asset's market cap is ï¿¥176.9T, after moving -0.64% in the last day.
Tokenized Eli Lilly And Co is trading at ï¿¥199,266.91, with a tokenized market cap of ï¿¥7.73B and a 24-hour trading volume of ï¿¥359.43M. The tokenized asset has moved -0.50% in the past 24 hours.